Article citationsMore>>

R. E. Ferner, J. D. Lucas, M. J. O’Doherty, R. A. Hughes, M. A. Smith, B. F. Cronin and J. Bingham, “Evaluation of (18)fluorodeoxyglucose Positron Emission Tomography ((18)FDG PET) in the Detection of Malignant Peripheral Nerve Sheath Tumours Arising from within Plexiform Neurofibromas in Neurofibromatosis 1,” Journal of Neurology, Neurosurgery and Psychiatry, Vol. 68, No. 3, 2000, pp. 353-357. doi:10.1136/jnnp.68.3.353

has been cited by the following article:

• TITLE: Malignant Triton Tumor in the Abdominal Wall: A Case Report

  AUTHORS: Yoshiyuki Kitamura, Koichiro Abe, Shingo Baba, Takuro Isoda, Yasuhiro Maruoka, Yoshio Matsuo, Yuichiro Kubo, Akio Sakamoto, Hiroshi Nishimura, Masayuki Sasaki, Hiroshi Honda

  KEYWORDS: Malignant Triton Tumor (MTT); Malignant Peripheral Nerve Sheath Tumor (MPNST); 2-[F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

  JOURNAL NAME: Advances in Molecular Imaging, Vol.3 No.2, April 12, 2013

  ABSTRACT: Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor (MPNST) with rhabdomyosarcomatous differentiation. We report the case of a 54-year-old male without a history of neurofibromatosis type 1 (NF1) who had a growing abdominal wall tumor diagnosed as MTT. Computed tomography (CT), magnetic resonance imaging (MRI) and 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography/CT (FDG-PET/CT) were performed. The MRI and FDG-PET/CT indicated that the lateral component of the tumor was composed of many proliferative cells, corresponding to the histopathological finding of a cellular proliferation of spindle-shaped cells. In light of this case and previous reports, it is apparent that FDG-PET/CT is a helpful tool for distinguishing MTT from benign peripheral nerve sheath tumor.